Triage for a Turnaround: A Medtech Action Plan for COVID-19 Response

Published on January 19, 2023

COVID-19 is more than a health crisis and is infecting the medical technology business at an unprecedented pace. The impact of the pandemic appears to us through a mix of commercial symptoms, such as (1) significant reductions in sales mobility and interaction, (2) rapidly changing purchase demand profiles focused exclusively on procurement of COVID-19 related products, (3) substantial supply chain disruptions, and (4) increased risk aversion towards any investments or unnecessary spending on non-life-threatening, elective procedures. While this crisis represents an unprecedented challenge to all medical technology companies, we see equally unprecedented opportunity to set the direction for future success at an accelerated pace.

An initial observational review of the medical technology landscape illustrates the differences between subsectors, highlighting extreme variation in terms of commercial impact.  

Continue reading on website
Other news

3 Steps to Increase Electric Vehicle Sales With Customization

January 19, 2023
Customers purchasing a combustion-engine car are spoiled for choice in today’s market, having their pick of numerous engine-trim combinations per model. However, this doesn’t apply to electric vehicles (EV). If manufacturers want to increase electric vehicle sales, they need to rethink their trim level approach and adapt to customers’ needs. To achieve this, we have identified three simple steps.T

Opportunities and Challenges in China’s Reimbursement Landscape

January 19, 2023
Since National Reimbursement Drug List (NRDL) negotiations were first introduced in 2015 by China’s State Council and National Health and Family Planning Commission (NHFPC), national drug price negotiation for high-cost drugs has become a critical cost containment tool for Chinese payers, and a key opportunity for manufacturers to increase their sales in the Chinese market. In this article, we sha